Diana Tichy

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

Lisa Leypoldt, Diana Tichy, Britta Besemer et al. · Journal of Clinical Oncology · 2023 · 141 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Prediction of malignancy by a radiomic signature from contrast agent‐free diffusion MRI in suspicious breast lesions found on screening mammography.

Sebastian Bickelhaupt, Daniel Paech, Philipp Kickingereder et al. · Journal of Magnetic Resonance Imaging · 2017 · 138 citations

Medicine, Oncology, Radiology +17

Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla

Matthias Roethke, Timur H. Kuru, S. Schultze et al. · European Radiology · 2013 · 135 citations

Medicine, Radiology, Urology +16

Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC–Peptide Binding Data Set

Maria Bonsack, Stéphanie Hoppe, Jan Winter et al. · Cancer Immunology Research · 2019 · 89 citations

Life Sciences, Bioinformatics, Immunology +17

Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial

Hartmut Goldschmidt, K. Elias, Jan Dürig et al. · Leukemia · 2020 · 66 citations

Medicine, Hematology, Oncology +9